Skip to main content
. 2023 Jan 4;102(1):4–13. doi: 10.1038/s41374-021-00663-w

Table 5.

Comparison of CRISPR-based and RT-PCR assays.

Parameters or aspects CRISPR-based assays RT-PCR assays
Target gene E and N ORF1ab, N, E, and RdRP
TAT 30–40 min 4 h
Assay results Qualitative Quantitative
Specific instrument required No Yes
FDA or EUA approval Not yet Yes

E envelope protein, N nucleocapsid protein, EUA European emergency use authorization, FDA US Food and Drug Administration, ORF open reading frame, RdRp RNA-dependent RNA polymerase, TAT turn-around time.